Latest News by Industry
DUBLIN--(BUSINESS WIRE)--Nov 2, 2022--
The "Cancer Gene Therapy Market Share, Size, Trends, Industry Analysis Report, By Therapy, By End-Use, By Region, Segment Forecast, 2022 - 2030" report has been added to ResearchAndMarkets.com's offering.
The growing demand for cancer gene therapy in diagnosing diseases is expected to drive industry growth. Furthermore, increasing investment in R&D, technological advancement, well-established infrastructure, and awareness among the people are the major factors driving the demand.
In addition, the growing geriatric population across the countries such as India, Japan, the U.S., and China is likely to positively impact the demand for the treatment over the coming years. Furthermore, with the rising technological advancement in the medical sector with government initiatives, the industry is expected to expand.
The industry was negatively impacted during the COVID-19 pandemic. Hospitals were made available for COVID-19 treatment, thus resulting in the declination of industry, but post-pandemic, it is expected to grow.
Cancer Gene Therapy Market Report Highlights
The publisher has segmented the cancer gene therapy market report based on therapy, end-use, and region:
Cancer Gene Therapy, Therapy Outlook (Revenue - USD Billion, 2018 - 2030)
Cancer Gene Therapy, End-Use Outlook (Revenue - USD Billion, 2018 - 2030)
Cancer Gene Therapy, Regional Outlook (Revenue - USD Billion, 2018 - 2030)
Key Topics Covered:
1. Introduction
2. Executive Summary
3. Research Methodology
4. Global Cancer Gene Therapy Market Insights
5. Global Cancer Gene Therapy Market, by Therapy
6. Global Cancer Gene Therapy Market, by End-Use
7. Global Cancer Gene Therapy Market, by Geography
8. Competitive Landscape
9. Company Profiles
Companies Mentioned
For more information about this report visit https://www.researchandmarkets.com/r/n35wii
View source version on businesswire.com:https://www.businesswire.com/news/home/20221102005916/en/
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
KEYWORD:
INDUSTRY KEYWORD: GENETICS HEALTH ONCOLOGY
SOURCE: Research and Markets
Copyright Business Wire 2022.
PUB: 11/02/2022 01:30 PM/DISC: 11/02/2022 01:32 PM
http://www.businesswire.com/news/home/20221102005916/en